Gerresheimer manufactures specialized packaging and drug-delivery systems for the pharmaceutical, biotech and cosmetics industries. Core products include glass vials, ampoules, syringes, inhalers, injectors and plastic primary packaging engineered for sterile and sensitive formulations. The company combines glass and plastics know-how with regulated manufacturing to serve global drugmakers that need reliable containment and dosing solutions. Its niche is high-specification primary packaging rather than mass consumer bottles.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 568.9 | — | 37 | — |
| Q1 2025 | 520 | — | -18 | — |
| Q2 2025 | 600.6 | — | 17 | — |
| Q4 2025 | 639.5 | 12.4% | -306.6 | -927.8% |
All markets — KeepWinning global stock screener
Other companies on MDAX: Evotec (EVT), Stabilus (STM), HelloFresh (HFG), Talanx (TLX), Hochtief (HOT), Traton (8TRA)